185
Views
1
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Association between anticholinergic burden and hospital readmission in older patients: a prospective analysis

, , , ORCID Icon, & ORCID Icon
Pages 104-109 | Received 05 Jun 2020, Accepted 09 Oct 2020, Published online: 26 Oct 2020

References

  • Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001 Jan 7;62(suppl 21):11–4.
  • Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993 july 1;3(4):335–48.
  • Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007 août;63(8):725–31.
  • Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997 July 28;157(14):1531–6.
  • Fox C, Smith T, Maidment I, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014 Sept;43(5):604–15.
  • Campanelli CM. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012 avr;60(4):616–31.
  • Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008 March 10;168(5):508–13.
  • Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ avr. 2018;361:k1315.
  • Villalba-Moreno AM, Alfaro-Lara ER, Pérez-Guerrero MC, et al. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr. 2016 Jan 1;62:1–8.
  • Naples JG, Marcum ZA, Perera S, et al. Concordance between anticholinergic burden scales. J Am Geriatr Soc. 2015 Oct;63(10):2120–2124.
  • Coupland CAC, Moore M, Hippisley-Cox J. Association of anticholinergic drug exposure with increased occurrence of dementia-reply. JAMA Intern Med. 2019 Dec 1;179(12):1730–1731.
  • Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case- control study. BMJ. 2018 Apr;25(361):k1315.
  • Campbell NL, Perkins AJ, Bradt P, et al. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population. Pharmacotherapy. 2016 Nov;36(11):1123–31.
  • Gray SL, Anderson M, Hubbard R. Anticholinergic use with incident dementia–reply. JAMA Intern Med. 2015 Sep;175(9):1577.
  • Moustafa N, Jadwiga Z, Sanaa H, et al. In geriatric patients, delirium symptoms are related to the anticholinergic burden. Geriatr Gerontol Int. 2016 1 avr;16(4):424–31.
  • Tune LE, Bylsma FW, Hilt DC Anticholinergic delirium caused by topical homatropine ophthalmologic solution: confirmation by anticholinergic radioreceptor assay in two cases. J Neuropsychiatry Clin Neurosci. Spring 1992;4(2):195–197.
  • Flacker JM, Cummings V, Mach JR Jr, et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry. 1998 Winter;6(1):31–41.
  • Nishtala PS, Narayan SW, Wang T, et al. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753‑8.
  • Zia A, Kamaruzzaman S, Myint PK, et al. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016 Feb;84:32–37.
  • Huang K-H, Chan F, Shih H, et al. Relationship between potentially inappropriate anticholinergic drugs (PIADs) and adverse outcomes among elderly patients in Taiwan. J Food Drug Anal. 2012;20(4):930–7.
  • Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015 march;15:31.
  • Uusvaara J, Pitkala KH, Kautiainen H, et al. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study. Drugs Aging. 2011 févr;28(2):131–138.
  • Dispennette R, Elliott D, Nguyen L, et al. Drug Burden Index score and anticholinergic risk scale as predictors of readmission to the hospital. Consult Pharm J Am Soc Consult Pharm. 2014 march;29(3):158‑68.
  • Kalisch Ellet LM, Pratt NL, Ramsay EN, et al. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J AM Geriatr Soc. 2014;62(10):1916–1922.
  • Gutiérrez-Valencia M, Martínez-Velilla N, DL V, et al. Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study. Eur J Clin Pharmacol. 2017 Nov;73(11):1467–1474.
  • Deplanque D, Sénéchal-Cohen S, Lemaire F. participants of giens XXXII, round table n(o) 5. French Jardé’s Law and European regulation on drug trials: harmonization and implementation of new rules. Therapie. 2017 Feb;72(1):73–80.
  • Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, et al. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc. 2014;62:342–346.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
  • Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. the index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963 Sep;21(185):914–919.
  • Monégat M, Sermet C. La polymédication: définitions, mesures et enjeux. Questions d'économie de la santé. 2014;204:8.
  • Legrain PS. Consommation Médicamenteuse chez le Sujet Agé. Haute Aut Santé. 2005;16:1–16.
  • Carnahan RM, Lund BC, Perry PJ, et al. The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Psychopharmacol Bull. 2002;36:14–19.
  • Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;16:508–513.
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. Available from: http://www.R-project.org/
  • Narayan SW, Hilmer SN, Horsburgh S, et al. Anticholinergic component of the drug burden index and the anticholinergic drug scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging. 2013 Nov 1;30(11):927–34.
  • Beuscart J-B, Dupont C, Defebvre -M-M, et al. Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: A population based study in a French region. Arch Gerontol Geriatr. 2014 Nov 1;59(3):630–5.
  • Durán CE, Azermai M, Stichele RHV. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013 July 1;69(7):1485–96.
  • Ablett AD, Browning A, Quan V, et al. Anti-cholinergic burden and patient related clinical outcomes in an emergency general surgical setting. Asian J Surg avr. 2019;42(4):527–34.
  • Kimberley R, Woodman Richard J, Mangoni Arduino A. Drugs with anticholinergic effects and cognitive impairment, falls and all‐cause mortality in older adults: A systematic review and meta‐analysis. Br J Clin Pharmacol. 2015 July 21;80(2):209–20.
  • Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med. 2009 Déc;122(12):1142–1149.
  • Gnjidic D, Hilmer SN, Hartikainen S, et al. Impact of high risk drug on hospitalization and mortality in older people with and without Alzheimer’s disease: a national population cohort study. PLoS ONE. 2014;9(1):e83224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.